Santa-Barbara political economy professor Benjamin Cohen proposes new fiscal stimulus to complement the current low-interest-rate monetary policy.

Daphne Basel

2019-08-28 14:46:00 Wed ET

Santa-Barbara political economy professor Benjamin Cohen proposes new fiscal stimulus to complement the current low-interest-rate monetary policy. Cohen finds that global interest rates persist at low thresholds in the current decade. In OECD and several other economies, low interest rates cannot bounce back too far from the zero lower bound during the global financial crisis.

In Europe, Japan, and Switzerland, the risk-free interest rates fall below zero. In this context, most central banks have little room for new interest rate reductions as the global economy gradually moves toward the next recession. In response to the current Sino-U.S. trade truce and Brexit economic uncertainty, Cohen proposes new countercyclical fiscal stimulus as a key alternative policy instrument for global economic revival. This new fiscal stimulus can manifest in the generic form of tax credits, transfer payments, and public expenditures in health care, infrastructure, education, and technology. Nevertheless, Cohen adds the cautionary caveat that lawmakers may remain reluctant to increase core fiscal deficits on top of post-crisis national debt mountains. To the extent that legislators become wary of backlash in parliamentary elections, it is important for politicians and technocrats to strike a better balance between democratic accountability and elite interest entrenchment.

 


If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.

Blog+More

Donald Trump defies the odds to become the new U.S. president.

John Fourier

2016-11-08 00:00:00 Tuesday ET

Donald Trump defies the odds to become the new U.S. president.

Donald Trump defies the odds to become the new U.S. president. He wants to make America great again. He seeks to repeal Obamacare. He has zero tole

+See More

The unique controversial management style of Steve Jobs helps translate his business acumen into smart product development.

Dan Rochefort

2020-03-26 10:31:00 Thursday ET

The unique controversial management style of Steve Jobs helps translate his business acumen into smart product development.

The unique controversial management style of Steve Jobs helps translate his business acumen into smart product development. Jay Elliot (2012) Leading

+See More

The Sino-American trade war may slash global GDP by $600 billion.

Monica McNeil

2019-06-15 10:28:00 Saturday ET

The Sino-American trade war may slash global GDP by $600 billion.

The Sino-American trade war may slash global GDP by $600 billion. If the Trump administration imposes tariffs on all the Chinese imports and China retaliate

+See More

Tax policy pluralism for addressing special interests

Monica McNeil

2023-12-08 08:28:00 Friday ET

Tax policy pluralism for addressing special interests

Tax policy pluralism for addressing special interests Economists often praise as pluralism the interplay of special interest groups in public policy. In

+See More

House Judiciary Committee summons senior executive reps of the tech titans to assess online platforms and their market power.

Peter Prince

2019-08-18 11:33:00 Sunday ET

House Judiciary Committee summons senior executive reps of the tech titans to assess online platforms and their market power.

House Judiciary Committee summons senior executive reps of the tech titans to assess online platforms and their market power. These companies are Facebook,

+See More

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

Monica McNeil

2025-10-31 12:26:00 Friday ET

The global market for GLP-1 weight-loss medications can grow substantially to benefit more than 1 billion people worldwide by 2030.

With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi

+See More